35629-71-1,
4-(trifluoromethyl)oxazol-2-amine,
2-Amino-4-trifluoromethyloxazole,
4-(trifluoromethyl)-1,3-oxazol-2-amine,
4-Trifluoromethyl-oxazol-2-ylamine,
2-amino-4-(trifluoromethyl)oxazole,
2-Oxazolamine, 4-(trifluoromethyl)-,
MFCD07777221,
4-(Trifluoromethyl)-2-Oxazolamine,
AC1MC7XL,
SCHEMBL2374152,
CTK4H5009,
DTXSID60376798,
LUSFWEXIRSHBNN-UHFFFAOYSA-N,
4-(Trifluoromethyl)oxazole-2-amine,
ZINC4198753,
2-Oxazolamine,4-(trifluoromethyl)-,
SBB051931,
AKOS005255409,
AB42401,
CS-W006806,
DS-2971,
FS-2031,
RP01728,
KS-0000259B,
[4-(trifluoromethyl)-oxazol-2-yl]-amine,
AJ-48246,
AK135041,
CJ-11361,
EN001416,
SC-32798,
4-(trifluoromethyl)-1,3-oxazole-2-amine,
A2071M500,
AB0041141,
DB-017477,
ST2418055,
TR-038780,
2-amino-4-trifluoromethyloxazole, AldrichCPR,
4-(trifluoromethyl)-1,3-oxazole-2-ylamine,
4CH-012955,
AM20090563,
FT-0685287,
Y8848,
A18683,
C-1799,
629T711,
J-513927,
Z1741966817,
2-Amino-4- oxazole,
C4H3F3N2O,
ZINC04198753,
CID2763188,